BerandaDNABW • OTCMKTS
add
Ginkgo Bioworks
Tutup sebelumnya
$0,0061
Rentang hari
$0,0061 - $0,0061
Rentang tahun
$0,00050 - $0,025
Kapitalisasi pasar
405,60 jt USD
Volume Rata-Rata
42,34 rb
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 43,85 jt | 26,16% |
Biaya operasional | 128,36 jt | -29,52% |
Laba bersih | -107,53 jt | 49,20% |
Margin laba bersih | -245,25 | 59,74% |
Penghasilan per saham | -1,21 | 58,78% |
EBITDA | -78,48 jt | 44,39% |
Tarif pajak efektif | 0,30% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 561,57 jt | -40,52% |
Total aset | 1,38 M | -17,29% |
Total liabilitas | 661,39 jt | 16,40% |
Total ekuitas | 716,06 jt | — |
Saham yang beredar | 54,37 jt | — |
Harga terhadap nilai buku | 0,00 | — |
Tingkat pengembalian aset | -16,47% | — |
Tingkat pengembalian modal | -19,39% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -107,53 jt | 49,20% |
Kas dari operasi | -42,44 jt | 26,62% |
Kas dari investasi | -13,08 jt | 71,97% |
Kas dari pembiayaan | -203,00 rb | 67,88% |
Perubahan kas bersih | -55,80 jt | 46,88% |
Arus kas bebas | -64,47 jt | -146,17% |
Tentang
Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT, headed by Jason Kelly. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021. Wikipedia
CEO
Didirikan
2008
Kantor pusat
Situs
Karyawan
834
